Patient advocates, congressional staff and researchers to discuss how the federal government can increase clinical trials awareness
Patient advocates, congressional staff and researchers to discuss how the federal government can increase clinical trials awareness
Washington, DC – The Coalition for Clinical Trials Awareness (CCTA), of which the Alliance for Patient Access is the managing member, will host a Capitol Hill policy roundtable on Wednesday, May 3, “How Can the Federal Government Increase Clinical Trials Awareness?” The event, offering perspectives from patient advocates, an FDA official and a researcher, will discuss how the federal government can develop a strategy to increase clinical trials awareness and address the clinical trials under-enrollment problem. Congresswoman Diana DeGette (D-CO) will provide remarks highlighting the importance of clinical trials awareness and participation.
The event is part of the nationwide Clinical Trials Awareness Week, May 1-5, which is hosted by CCTA. The week’s activities also include a Twitter chat on May 2 and a social media campaign, “Cures begin with clinical trials awareness.”
Clinical trials are an essential step in getting medications approved by the FDA and onto pharmacy shelves for patients. Currently, there is a severe shortage of clinical trial participants, which slows the process of approving medications and moving them to market for patients. One study reported that 11% of clinical trials fail to enroll even one participant.
Consequently, many groundbreaking, life-saving medications remain stuck in the drug development pipeline. With increased participation in clinical trials, however, patients and care providers will have greater access to approved medications.
Clinical Trials Awareness Capitol Hill Policy Roundtable
Wednesday, May 3
11:30 a.m. – 1 p.m.
U.S. Capitol Visitors Center
Room SVC 214
Washington, DC
Panelists:
About The Coalition for Clinical Trials Awareness
The Coalition for Clinical Trials Awareness is a nonprofit group of health care providers, patient advocates, medical researchers and industry and government stakeholders working together to increase public awareness about the importance of clinical trials participation. http://cctawareness.org/
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.